{"disease":{"id":"acute-lymphoblastic-leukemia-with-failed-remission","name":"acute lymphoblastic leukemia with failed remission"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03919240","title":"CAR-T Cell Therapy Targeting to CD19 for R/R ALL","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":196,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT03751072","title":"Efficacy and Toxicity of Blinatumomab in the French ATU for Adult BCP-ALL R/R, or With MRD+ (FRENCH-CYTO)","phase":"","overall_status":"COMPLETED","enrollment_count":92,"lead_sponsor_name":"Group for Research in Adult Acute Lymphoblastic Leukemia","has_results":false},{"nct_id":"NCT05809284","title":"Determining the Mechanisms of Loss of CAR T Cell Persistence","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT05292664","title":"Venetoclax Basket Trial for High Risk Hematologic Malignancies","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Andrew E. Place, MD","has_results":false},{"nct_id":"NCT03515200","title":"Treatment With Combination Chemotherapy for Relapsed or Refractory Acute Lymphoblastic Leukemia","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":12,"lead_sponsor_name":"St. Jude Children's Research Hospital","has_results":false},{"nct_id":"NCT04049383","title":"CAR-20/19-T Cells in Patients With Relapsed/Refractory B Cell ALL","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":5,"lead_sponsor_name":"Medical College of Wisconsin","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}